Narcolepsy – Pipeline Review, Q2 2011
Narcolepsy - Pipeline Review, Q2 2011
Reference Code: GMDHC632IDB
Publication Date: June 2011
Narcolepsy – Pipeline Review, Q2 2011 GMDHC632IDB / Pub June 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied
Page(1)
Narcolepsy – Pipeline Review, Q2 2011
Ta b le o f Co n te n ts
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Narcolepsy Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Narcolepsy 7
Narcolepsy Therapeutics under Development by Companies 9
Narcolepsy Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Early Clinical Stage Products 13
Comparative Analysis 13
Pre-Clinical Stage Products 14
Comparative Analysis 14
Narcolepsy Therapeutics - Products under Development by Companies 15
Narcolepsy Therapeutics - Products under Investigation by Universities/Institutes 16
Companies Involved in Narcolepsy Therapeutics Development 17
Johnson & Johnson 17
Evotec Aktiengesellschaft 17
Arena Pharmaceuticals, Inc. 18
BIOPROJET SCR 18
Narcolepsy - Therapeutics Assessment 19
Assessment by Monotherapy Products 19
Assessment by Combination Products 20
Assessment by Route of Administration 21
Assessment by Molecule Type 23
Drug Profiles 25
APD916 - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
BF2.649 - Drug Profile 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Biaxin - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
JNJ-17216498 - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Narcolepsy – Pipeline Review, Q2 2011 GMDHC632IDB / Pub June 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied Page(2)
Narcolepsy – Pipeline Review, Q2 2011
EVT501 - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
BF2.649 + Modafinil - Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Narcolepsy Therapeutics – Drug Profile Updates 33
Narcolepsy Therapeutics - Discontinued Products 34
Narcolepsy - Featured News 35
Oct 20, 2010: Arena Announces Phase I Results For APD916 For Treatment Of Narcolepsy With Cataplexy 35
Appendix 36
Methodology 36
Coverage 36
Secondary Research 36
Primary Research 36
Expert Panel Validation 37
Contact Us